Pharma Journalist - Page 6 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Alloy, Biogen Partner on Next-Gen Antisense Therapies

Neurocrine to Acquire Soleno in $2.9 Billion Deal

Apnimed Secures $150M to Advance Sleep Apnea Drug Launch

Akari Partners with WuXi XDC on Novel Cancer Therapy

Lilly to Acquire Centessa in $6.3 Billion Deal

Teva Advances Biosimilars With FDA Approval and Filings

Symeres, Ambagon Partner on Novel Cancer Drug Approach

Biogen to Acquire Apellis in $5.6 Billion Deal

FDA Approves Higher-Dose Spinraza Regimen for SMA Patients

In Vivo Cell Engineering Reaches an Inflection Point as the 5th In Vivo Cell Engineering & Gene Editing Summit Returns to Boston